CrushSCI.com
89.0Average days
77Median days
21Fastest days
258Longest days
5252025 publications

Paper Review Records

All Paper Review Records

29 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

21 days

Autoinflammatory Keratinization Diseases (AiKDs): An Updated List of Diseases and Evolving Treatments

Authors
Masashi AkiyamaShow moreShow less
Affiliations
1. Department of Dermatology and Skin Disease Research Institute Shin‐Yurigaoka General Hospital Kawasaki Japan; 2. Department of Dermatology Nagoya University Graduate School of Medicine Nagoya JapanShow moreShow less
Source PDF DOI Publisher page
70 days

Successful Sequential IL ‐36 and IL ‐17 Blockade Therapy for Hydroxychloroquine‐Induced Generalized Pustular Psoriasis

Authors
Hiromu Tsuji; Yukino Yamamoto; Tomoyuki Hioki; En Shu; Hiroaki IwataShow moreShow less
Affiliations
1. Department of Dermatology Gifu University Graduate School of Medicine Gifu Japan; 2. Center for Clinical Training and Career Development Gifu University Hospital Gifu JapanShow moreShow less
Source PDF DOI Publisher page
76 days

Stage‐Specific Prognosis and Treatment Outcomes in Extramammary Paget's Disease: A Retrospective Single‐Center Study of 104 Japanese Patients

Authors
Manami Takahashi‐Watanabe; Taku Fujimura; Airi Kobayashi; Emi Yamazaki; Erika Tamabuchi; Yusuke Muto; Yumi Kambayashi; Yoshihide AsanoShow moreShow less
Affiliations
1. Department of Dermatology Tohoku University Graduate School of Medicine Sendai JapanShow moreShow less
Source PDF DOI Publisher page
110 days

Study Design and Baseline Characteristics of APOLLO : A Phase 3 Study of Bitopertin in Erythropoietic Protoporphyria and X‐Linked Protoporphyria

Authors
Amy Yeung; Mark Amster; Karl E. Anderson; Manisha Balwani; Herbert L. Bonkovsky; Edward Cordasco; Manuchehr Darani; Petra De Haes; Laurent Gouya; Siobán Keel; Ilja Kubisch; Janneke Langendonk; Cynthia Levy; Tasneem F. Mohammad; Manuel P. Pereira; Robert Sarkany; Bruce Wang; Melanie Chin; Will Savage; Gayle Ross; APOLLO InvestigatorsShow moreShow less
Affiliations
1. Harvard Medical School and Massachusetts General Hospital Boston Massachusetts USA; 2. MetroBoston Clinical Partners Boston Massachusetts USA; 3. University of Texas Medical Branch Galveston Texas USA; 4. Icahn School of Medicine at Mount Sinai New York USA; 5. School of Medicine and Atrium Health Wake Forest Baptist Wake Forest University Winston‐Salem North Carolina USA; 6. Remington‐David Clinical Research Columbus Ohio USA; 7. Marvel Clinical Research Huntington Beach California USA; 8. Universitair Ziekenhuis Leuven Leuven Belgium; 9. University of Paris Paris France; 10. Fred Hutch Cancer Institute University of Washington Seattle Washington USA; 11. Klinikum Chemnitz gGmbH Chemnitz Germany; 12. Erasmus MC University Medical Center Rotterdam Rotterdam the Netherlands; 13. Miller School of Medicine University of Miami Miami Florida USA; 14. Henry Ford Health Detroit Michigan USA; 15. Corporate Member of Freie Universität Berlin and Humboldt‐Universität zu Berlin, Institute of Allergology Charité—University Medical Center Berlin Berlin Germany; 16. Guy's and St. Thomas' Hospitals London UK; 17. University of California San Francisco Porphyria Center San Francisco California USA; 18. Disc Medicine Watertown Massachusetts USA; 19. Royal Melbourne Hospital Melbourne AustraliaShow moreShow less
Source PDF DOI Publisher page
36 days

Infantile Benzalkonium Chloride–Associated Hyperkeratotic Flexural Erythema

Authors
Yan Wang; Zigang XuShow moreShow less
Affiliations
1. Department of Dermatology, Beijing Children's Hospital Capital Medical University, National Center for Children's Health Beijing ChinaShow moreShow less
Source PDF DOI Publisher page
43 days

Hypogammaglobulinemia and Infection After Rituximab in Pemphigus, With Divergent Desmoglein Antibody and Immunoglobulin Kinetics: A Retrospective Cohort Study

Authors
Ece Gökyayla; Mert Bardak; Hakan Koçer; Nezahat Nehir Mızraklı; İdil Ünal; İlgen Ertam Sağduyu; Işıl Karaarslan; Nilay Duman; Ayda AcarShow moreShow less
Affiliations
1. Department of Dermatology and Venereology Faculty of Medicine, Ege University Izmir Türkiye; 2. Private Practice Izmir TürkiyeShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does JOURNAL OF DERMATOLOGY take to review a manuscript?

As of 2026-11-17, CrushSCI has 29 complete review records for JOURNAL OF DERMATOLOGY. The fastest paper went from submission to acceptance in 21 days (Autoinflammatory Keratinization Diseases (AiKDs): An Updated List of Diseases and Evolving Treatments, received 2026-10-16, accepted 2026-11-06); the slowest took 258 days. The average is 89.0 days and the median is 77 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.